Learn / PathologyChronic Inflammation & Granulomas

Pathology

Chronic Inflammation & Granulomas

Persistent injury, macrophage–lymphocyte signalling, fibrosis and granulomatous patterns.

9 min readUpdated 10 August 2026
Begin lesson

Key points before the detail

  1. 01

    Chronic inflammation combines inflammation, tissue destruction and repair at the same time.

  2. 02

    Macrophages and lymphocytes maintain one another through cytokine signalling.

  3. 03

    TGF-β and related growth-factor signalling promotes fibroblast activation and collagen deposition.

  4. 04

    Granuloma is a morphological reaction pattern; necrotising, non-necrotising, suppurative and foreign-body patterns have different differentials.

Section 01

The chronic inflammatory pattern

Persistent infection, immune-mediated disease, prolonged exposure to foreign material and some tumour-associated processes can sustain inflammation. Unlike a short neutrophil-dominant response, chronic inflammation often features macrophages and lymphocytes alongside variable plasma cells, eosinophils and other recruited cells.

Section 02

Macrophages as central organisers

Macrophages phagocytose material, present antigen, release cytokines and growth factors, and can drive either continued tissue injury or repair. T-cell-derived signals activate macrophages, while macrophage cytokines recruit and activate lymphocytes, creating a self-sustaining circuit when the initiating stimulus persists.

Section 03

Why chronic inflammation causes structural disease

Repair pathways stimulate angiogenesis, fibroblast proliferation and extracellular-matrix deposition. TGF-β is a particularly important profibrotic signal, with PDGF and other mediators contributing. The resulting scar can be protective, but in hollow organs and surgical planes it can cause strictures, obstruction, adhesions, sinus tracts or fistulae.

Section 04

What is a granuloma?

A granuloma is an organised focus of activated macrophages that take on an epithelioid appearance, commonly surrounded by lymphocytes. Multinucleated giant cells may form. Granulomas develop when the immune system attempts to contain a persistent stimulus that is difficult to eradicate or digest.

Section 05

Granulomatous patterns

PatternHow to think about it
NecrotisingRaises infectious causes such as mycobacterial or fungal disease, but morphology alone does not identify the organism.
Non-necrotisingSeen in immune-mediated and some infectious conditions; requires clinical and microbiological context.
Foreign-bodyMacrophages/giant cells form around exogenous or endogenous material that is difficult to phagocytose.
SuppurativeGranulomatous inflammation with a prominent neutrophilic/purulent component in selected infections or foreign-body reactions.
ReadingRetrieval

Close the notes and answer these

Try each question from memory before revealing the answer. These public prompts are a small preview of the integrated retrieval system inside SurgAtlas.

01Which two cell groups are particularly prominent in chronic inflammation?
Answer

Macrophages and lymphocytes.

02Why can chronic inflammation produce strictures?
Answer

Persistent repair signalling activates fibroblasts and extracellular-matrix/collagen deposition, which contracts and remodels tissue.

03Is a granuloma itself a diagnosis?
Answer

No. It is a histological reaction pattern whose cause must be interpreted using morphology, stains/microbiology and clinical context.

References & editorial basis

  1. SurgAtlas production chapter — Chronic Inflammation and Granulomas. Primary source for this public lesson. The public teaching is a condensed, source-derived version of the corresponding production pathology chapter.
  2. Robbins & Cotran Pathologic Basis of Disease. Reference for stable chronic-inflammatory and granulomatous pathology.

This lesson is derived from the corresponding SurgAtlas production teaching material. Where the source makes current management or guideline claims, the public lesson uses the cited contemporary guidance. It is written for education and examination preparation, not as patient-specific clinical advice.

Editorial details
Author & editorDr. Ali Heidari

Medical Doctor (MD) · MRCS Part A · Physician · Surgical Educator

Published 10 August 2026Updated 10 August 2026
Clinical use

SurgAtlas is an educational resource. For patient care, verify current national guidance, local antimicrobial and transfusion policies, specialty pathways and individual patient factors.

Turn reading into retrieval.

Use the full learning workspace for chapter progress, integrated questions, review scheduling and exam-focused study tools. Free accounts do not include recurring AI usage.

Start Learning Free